Jehoovah Pharmaceutical And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.20 M
as on 06-07-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
About Jehoovah Pharmaceutical And Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Minakhi Choudhury, Nrusinghanath Nanda, and Paresh Bohidar serve as directors at the Company.
- CIN/LLPIN
U85100OR2015PTC018591
- Company No.
018591
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2015
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jehoovah Pharmaceutical And Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minakhi Choudhury  | Director | 03-Feb-2022 | Current |
| Nrusinghanath Nanda | Director | 01-Apr-2019 | Current |
| Paresh Bohidar | Director | Current |
Financial Performance of Jehoovah Pharmaceutical And Healthcare.
Jehoovah Pharmaceutical And Healthcare Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jehoovah Pharmaceutical And Healthcare?
In 2017, Jehoovah Pharmaceutical And Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jehoovah Media Worlds Private LimitedActive 5 years 10 daysMinakhi Choudhury and Nrusinghanath Nanda are mutual person
- Jehoovah 4Lifecare Private LimitedActive 4 years 11 months
Minakhi Choudhury and Nrusinghanath Nanda are mutual person
- Jehoovah Charitable FoundationActive 1 year 11 months
Minakhi Choudhury and Nrusinghanath Nanda are mutual person
- Jehoovah Infracon Private LimitedActive 12 years 14 days
Nrusinghanath Nanda and Paresh Bohidar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jehoovah Pharmaceutical And Healthcare?
Unlock and access historical data on people associated with Jehoovah Pharmaceutical And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jehoovah Pharmaceutical And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jehoovah Pharmaceutical And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
